StonvexLoading…
StonvexStonvexStonvexCore line items from INV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-10-01 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $2.06M | $456.00K | $764.00K | $1.12M |
Operating Income | $-464.70M | $-40.30M | $-36.78M | $-23.68M |
Net Income | $-293.32M | $-61.75M | $-16.44M | $-30.84M |
EPS (Diluted) | $-5.39 | $-1.41 | Not available | Not available |
Total Assets | $599.19M | $905.29M | Not available | $21.56M |
Total Liabilities | $115.51M | $139.00M | Not available | $29.42M |
Cash & Equivalents | $60.45M | $11.12M | $45.00K | $2.58M |
Free Cash Flow OCF − CapEx | $-82.10M | $-29.48M | $-19.58M | $-20.12M |
Shares Outstanding | 67.74M | 44.60M | Not available | Not available |